Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Professor Hardisty was added as an investigator to the Clinical Trial Exemption for Armour's heat-treated Factorate.

  • Read more about Professor Hardisty was added as an investigator to the Clinical Trial Exemption for Armour's heat-treated Factorate.

At Great Ormond Street Hospital in 1984 NHS Factor 8 concentrate was the blood product used the most. There was a significant reduction in the amount of commercial concentrate used.

  • Read more about At Great Ormond Street Hospital in 1984 NHS Factor 8 concentrate was the blood product used the most. There was a significant reduction in the amount of commercial concentrate used.

At Great Ormond Street Hospital in 1983, there was increased use of NHS Factor 8, little use of cryoprecipitate, and the volume of Factorate fell substantially compared to the previous year.

  • Read more about At Great Ormond Street Hospital in 1983, there was increased use of NHS Factor 8, little use of cryoprecipitate, and the volume of Factorate fell substantially compared to the previous year.

1,339,864 units of Factorate were used at Great Ormond Street Hospital in 1982 (and 35,599 units of Hemofil), together with 205,348 units of NHS Factor 8 and 18,620 units of cryoprecipitate.

  • Read more about 1,339,864 units of Factorate were used at Great Ormond Street Hospital in 1982 (and 35,599 units of Hemofil), together with 205,348 units of NHS Factor 8 and 18,620 units of cryoprecipitate.

The mother of a child treated at GOSH, Della Ryness-Hirsch, protested when her son's treatment was changed from cryoprecipitate to Factor 8, but was told that there was not enough cryoprecipitate available and that NHS Factor 8 was perfectly safe.

  • Read more about The mother of a child treated at GOSH, Della Ryness-Hirsch, protested when her son's treatment was changed from cryoprecipitate to Factor 8, but was told that there was not enough cryoprecipitate available and that NHS Factor 8 was perfectly safe.

432,326 units of Factorate were used at Great Ormond Street in 1980 (and 116,877 units of Kryobulin), together with 128,859 units of NHS Factor 8 and 22,890 units of cryoprecipitate.

  • Read more about 432,326 units of Factorate were used at Great Ormond Street in 1980 (and 116,877 units of Kryobulin), together with 128,859 units of NHS Factor 8 and 22,890 units of cryoprecipitate.

463,441 units of Factorate were used at Great Ormond Street Hospital in 1979 (and a modest amount of Koate: 1,590 units), together with 159,675 units of NHS Factor 8 and 62,720 units of cryoprecipitate.

  • Read more about 463,441 units of Factorate were used at Great Ormond Street Hospital in 1979 (and a modest amount of Koate: 1,590 units), together with 159,675 units of NHS Factor 8 and 62,720 units of cryoprecipitate.

There was an increase in the use of cryoprecipitate and NHS factor at Great Ormond Street Hospital but most treatment (501,214 units) was with commercial concentrates (Factorate and Koate), for the treatment of 42 patients.

  • Read more about There was an increase in the use of cryoprecipitate and NHS factor at Great Ormond Street Hospital but most treatment (501,214 units) was with commercial concentrates (Factorate and Koate), for the treatment of 42 patients.

The amount of cryoprecipitate used by Great Ormond Street Hospital reduced in 1977, with some rise in NHS Factor 8 but treatment was predominantly with commercial concentrates.

  • Read more about The amount of cryoprecipitate used by Great Ormond Street Hospital reduced in 1977, with some rise in NHS Factor 8 but treatment was predominantly with commercial concentrates.

At Great Ormond Street Hospital in 1976 there was substantial use of both cryoprecipitate and commercial concentrates, with very little NHS concentrate used.

  • Read more about At Great Ormond Street Hospital in 1976 there was substantial use of both cryoprecipitate and commercial concentrates, with very little NHS concentrate used.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Current page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.